BAJAJ BROKING

Notification close image
No new Notification messages
card image
Oswal Pumps IPO is Open!
Apply for the Oswal Pumps IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

Sun Pharma Faces FDA Heat; ITC Expands Organic Play as DIIs Offset FII Sell-off

Synopsis:

Markets slipped amid Middle East tensions and FII outflows. Sun Pharma faced USFDA action, while ITC expanded its organic portfolio. DIIs provided support as volatility rose, with Nifty showing signs of short-term weakness. Stay updated with Bajaj Broking.


Welcome to Markets Daily by Bajaj Broking, your go-to destination for market intelligence and updates that keep you ahead of the curve. Don’t forget to check out our Morning Podcast for more updates!

Also Read: Stock Market Live Updates

Sun Pharma Faces FDA Heat; ITC Expands Organic Play as DIIs Offset FII Sell-off

Global Market Overview

Global markets ended on a weak note last week as escalating geopolitical tensions rattled investors. Iran’s retaliatory missile strikes on Israel triggered a spike in crude oil and gold prices, while U.S. Treasury yields and the dollar also moved higher.

Major U.S. indices closed the week in the red:

Dow Jones fell 1.8%

Nasdaq Composite declined 1.3%

S&P 500 dropped 1.1%

This marked the end of a two-week winning streak for U.S. markets, with all three indices posting weekly losses. Energy stocks emerged as the only gainers amidst the turmoil.

Also Read: Oil Prices Soar 11% as Israeli Strikes on Iran Trigger Supply Fears

ITC LTD

Trade

418.24.30 (1.03 %)

Updated - 16 June 2025
418.90day high
DAY HIGH
413.25day low
DAY LOW
7006629
VOLUME (BSE)

Asian Market Snapshot

Asian equities showed signs of recovery on Monday:

Nikkei 225 gained 0.8%

Broader Asian indices edged up 0.2%

U.S. equity futures opened slightly higher

Despite the rebound, investor sentiment remains cautious due to the ongoing Middle East tensions and elevated oil prices.

Indian Market Highlights

Indian markets fell for a second straight session on Friday as geopolitical concerns and trade uncertainties weighed on investor sentiment.

Key Indices:

Sensex closed at 81,118.60, down 573.38 points (−0.70%)

Nifty ended at 24,718.60, down 169.60 points (−0.68%)

Sectoral Overview:

Media was the only sector to close in green

Notable laggards: FMCG, PSU Banks, Oil & Gas, Power, Telecom (−0.5% to −1%)

India VIX jumped over 7%, signaling increased market volatility

BSE Midcap and Smallcap indices dipped 0.3% each amid mild profit booking

Also Read: Genus Power: GIC Affiliate Plans Rs.650 Crore Stake Sale via Block Deal

Nifty Outlook: What to Expect

The Nifty formed a bullish candle on the daily chart but posted a lower high and lower low, pointing to a corrective bias. A bearish gap (24,901–24,790) and a breakdown below the 20-day EMA and rising trendline confirm short-term weakness.

Key Levels:

Resistance: 24,800 & 24,920

Support: 24,600 & 24,470

If Nifty closes above 25,000, it may signal the end of the correction.

If it breaks below 24,600, it could trigger a fall towards 24,400–24,500.

A breakdown below 24,400, especially amid worsening geopolitics, could spark a sharper decline.

Bank Nifty Levels

Resistance: 55,780 & 56,000

Support: 55,260 & 54,900

Gift Nifty Update

Gift Nifty indicates a flat start, with the broader market expected to move in a range of 24,400–24,900, in line with global cues and domestic uncertainty.

Options Corner

F&O data shows a consolidative trend:

Call writers are active near 25,000–25,200

Put support is seen near 24,400–24,500

Stock Buzz

Sun Pharma: Received a Form 483 with 8 observations from the USFDA for its Halol facility, raising regulatory red flags.

ITC: Completed a ₹400 crore acquisition of Sresta Natural Bioproducts, boosting its organic foods portfolio.

FII/DII Activity: FIIs: Net sold ₹1,263 crore, DIIs: Net bought ₹3,041 crore, offering support to the domestic market

Also Read: DCM Shriram to Acquire Hindusthan Specialty Chemicals for Rs.375 Crore

Share this article: 

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4.4 App Rating

icon-with-text

4 Languages

icon-with-text

₹5100+ Cr MTF Book

icon-with-text